Follow-Up Duration: From a few hours to several months, the follow-up duration varied greatly among the studies
MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet alLiraglutide and cardiovascular outcomes in type 2
In REDEFINE 1 (overweight/obesity without T2D), CagriSema achieved mean weight reductions of 20.4-22.7% (vs 2.3-3.0% placebo) at 68 weeks, with 53.6% and 34.7% of patients achieving 20% and 25% weight loss, respectively
A4: It could be shipped by sea,by air or by express(EMS,UPS,DHL,TNT,FEDEX and ect).Please confirm with us before placing orders
Pros of GLP-1 for Weight Loss Proven effectiveness: Clinical trials have demonstrated significant weight loss results with GLP-1, with participants losing an average of 15% of their body weight
doi:10.1177/20503121241275467